William A Lawton
Boehringer Ingelheim (United Kingdom)(GB)Boehringer Ingelheim (South Korea)(KR)Boehringer Ingelheim (Canada)(CA)
Publications by Year
Research Areas
Acute Ischemic Stroke Management, Antiplatelet Therapy and Cardiovascular Diseases, Stroke Rehabilitation and Recovery, Atrial Fibrillation Management and Outcomes, Blood Pressure and Hypertension Studies
Most-Cited Works
- → Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke(2008)965 cited
- → Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events(2008)778 cited
- → Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study(2008)357 cited
- → Effect of Four-Week Treatment with Oxitropium Bromide on Lung Mucociliary Clearance in Patients with Chronic Bronchitis or Asthma(1989)17 cited
- Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFE(2008)
- → Letter to the editor(1995)2 cited